TG Therapeutics, Inc.
News
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Purchased by Commonwealth Equity Services LLC
Ticker Report Commonwealth Equity Services LLC raised its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 1.3% during the second quarter, according to the company in its most recent Form...\n more…
TG Therapeutics, Inc. (NASDAQ:TGTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Zolmax TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six brokerages that are presently covering the company, MarketBeat.com reports...\n more…
Strategic Financial Concepts LLC Takes $530,000 Position in TG Therapeutics, Inc. (NASDAQ:TGTX)
Ticker Report Strategic Financial Concepts LLC acquired a new position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the second quarter, according to the company in its most recent disclosure with...\n more…
Zurcher Kantonalbank Zurich Cantonalbank Has $495,000 Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)
Ticker Report Zurcher Kantonalbank Zurich Cantonalbank decreased its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 2.2% during the second quarter, according to its most recent Form 13F...\n more…
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
Globe Newswire NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming data presentations, highlighting data from both the ULTIMATE I & II Phase...\n more…
nVerses Capital LLC Has $103,000 Stock Position in TG Therapeutics, Inc. (NASDAQ:TGTX)
Ticker Report nVerses Capital LLC lifted its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 34.9% in the 2nd quarter, Holdings Channel reports. The firm owned 5,800 shares of the...\n more…